NewcelX (NCEL) News
NASDAQ: NCELHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.54-0.15 (-5.58%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NCEL news summary
We found 2 recent headlines mentioning NewcelX (NCEL): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. NCEL is making an outsized move today, down 5.58% at $2.54, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market", was published by GlobeNewswire on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest NewcelX headlines
- NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to MarketThe financing led by international healthcare investors, alongside The Crushing T1 Foundation, reinforces confidence in NewcelX’s strategy and long-term potential The financing led by international…GlobeNewswire
- NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone PaymentsTransaction provides $500,000 upfront of which $30,000 is in cash and the remainder in shares , representing a 9.4% equity stake in REA Holdings, alongside potential worldwide royalties of up to 8%GlobeNewswire